Peer Review History
| Original SubmissionApril 9, 2021 |
|---|
|
PONE-D-21-11801 Isolation of the side population from adult neurogenic niches enriches for endothelial cells PLOS ONE Dear Dr. Lagace, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 11 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marietta Zille, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2) We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3) PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ Reviewers' comments: Reviewer #1: Review Kalinina et al. In the present manuscript Kalinina et al. report a FACS based method to isolate endothelial cells from mouse brain tissue. The main purpose of the work was to isolate neural stem cells from the gyrus and subventricular zone by gating for side population characterized by low fluorescence in cells that exhibit high efflux of DNA biding dyes. Meanwhile, no neural stem cells were present in the side population, however a large proportion expresses CD31 and the authors suggest these are endothelial cells. The manuscript is descriptive in nature and provides sound and well controlled protocol, that is relevant for peers studying endothelial cells to have access to. However, CD31 expressing cells my be of hematopoietic origin, and do not makeup the entire side population and this should be addressed in greater detail. Please find my suggestions below: Major comments 1. A more thorough characterization of the CD31 expressing cells is warranted to draw the conclusion that they are endothelial cells. While it is true that CD31 is a marker of endothelial cells, it should also be considered that white blood cell populations such as monocytes express CD31. This could be by immunohistochemistry, RNAscope, or qPCR using genes/proteins that are specific for endothelial cells1. This would also allow for full or tentative identification of the non CD31 expressing fraction of the side population. 2. The authors should indicate if the presented plots are pooled results of samples from more animals and the abundance of cells recovered from side populations from each brain. Please also include the variability on the protocol between experimental days, i.e. are the same number cells of the side populations obtained from each brain. This is relevant for the applicability of the protocol for isolation of endothelial cells for further studies by peers. Moreover, the authors are asked to systematically report how many mice were used in each experiment (e.g. in figure text) and gender proportion of included animals. Minor comments: Line 55-57: Could you include an indication of why it is particularly interesting to isolate cells form this place? Line 88: Please rephrase, the numbers are confusing. Please also consider that a C57BL/6J mouse is generally considered adult at 3 months of age2. Line 100: degree sign must be superscript 121: Cell � Cells 165: it is a bit confusing with the figure texts in the middle of the results paragraph. But I assume this is corrected in the final version. Figure text: please indicate how many mice were used to produce these plots Line 199: Please indicate the number of animals included in the production of these plots. And indicate the number of cells recovered in the side scatter Line 216: The authors write the cells are heterogeneous in size and DNA content. This supports the major comment 1. That more thorough characterization is called for. Preferably fixation and imaging. Line 217: Please include actual numbers of cell CD31 expressing cells, and number of animals included for each plot, could also be included in figure text (line 224). 274: please indicate actual populations size of side population preferably in proportion to main population. 281: Authors hypothesize that the CD31- proportion of the side population are microglia and hematopoietic cells – it would elevate the applicability of the protocol for peers significantly if the authors could provide more detailed information about this population. Figure 3 A and F: can the authors indicate variation in respect to samples in the quantification of CD31 proportions? 1. Vanlandewijck M, He L, Mae MA, et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018;554(7693):475-480. 2. Flurkey K, M. Currer J, Harrison DE. Chapter 20 - Mouse Models in Aging Research. In: Fox JG, Davisson MT, Quimby FW, Barthold SW, Newcomer CE, Smith AL, eds. The Mouse in Biomedical Research (Second Edition). Burlington: Academic Press; 2007:637-672. Reviewer #2: This is a very interesting manuscript using FACS for identification and isolation of endothelial cells from neurogenic niches. The authors interpreted the results nicely and the conclusions are comprehensible. The proposed method for identification of endothelial cells can be of specific use if dissociation procedures use enzymes, which may cleave the epitope of interest. Overall, the study appears to be performed carefully. In my opinion, there are no major concerns about the manuscript. Minor comments include: - Although the existence of the BBB is discussed in the manuscript, the authors might consider discussing it earlier in the manuscript. When talking about brain ECs, the BBB is a major part. Especially when addressing ABC transporters on brain ECs. - The authors could extend on the purity of the population when suggesting DCV staining as cheaper and easier option for EC isolation (254, 291) - The authors mention the number of animals used for the whole study. For quantification, it could be useful to include the number of animals or the SD in e.g. the figure legend for the reader to estimate. - Dentate gyrus, typo (229, 268) - Figure legend for Figure 2, SVZ is (B) (199) - Including a gating strategy to the figure would allow the reader to comprehend easily what is shown in the figure without going back to materials and methods section. While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Isolation of the side population from neurogenic niches enriches for endothelial cells PONE-D-21-11801R1 Dear Dr. Lagace, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Marietta Zille, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): All comments have been addressed. |
| Formally Accepted |
|
PONE-D-21-11801R1 Isolation of the side population from neurogenic niches enriches for endothelial cells Dear Dr. Lagace: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Dr. Marietta Zille Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .